Estrogen receptor (ER) ? expression in oligodendrocytes is required for attenuation of clinical dise...
Estrogen receptor (ER) ? expression in oligodendrocytes is required for attenuation of clinical disease by an ER[Beta] ligand
About this item
Full title
Author / Creator
Publisher
Washington: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
Washington: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
Treatment of experimental autoimmune encephalomyelitis (EAE) mice with the estrogen receptor (ER) β ligand diarylpropionitrile (DPN) has been shown to have neuroprotective effects via stimulation of endogenous myelination. The direct cellular mechanisms underlying the effects of this ERβ ligand on the central nervous system are uncertain because di...
Alternative Titles
Full title
Estrogen receptor (ER) ? expression in oligodendrocytes is required for attenuation of clinical disease by an ER[Beta] ligand
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1462413996
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1462413996
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
